No evidence of cross-reactivity of human antibodies to a 33-mer peptide of the alpha-gliadin component of gluten with Bordetella pertussis pertactin

Vaccine. 2005 May 9;23(25):3336-40. doi: 10.1016/j.vaccine.2005.01.078.

Abstract

A 33-mer peptide of the alpha-gliadin component of gluten was recently identified as primary initiator of the inflammatory response to gluten in coeliac disease (CD) patients. This proline-glutamine-rich peptide (PG-peptide) is highly homologous to internal sequence of pertactin, an immunogenic protein of Bordetella pertussis. Using enzyme immunoassays, we measured serum antibodies to pertactin and to PG-peptide in 167 Finnish subjects including pertussis vaccine recipients and pertussis patients, CD and non-CD patients and healthy individuals. We found no cross-reactivity between human antibodies to the two different components, suggesting that neither pertussis immunization nor disease contributes to the pathogenesis of CD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Bacterial / analysis
  • Antibodies, Bacterial / biosynthesis*
  • Antibody Specificity
  • Bacterial Outer Membrane Proteins / chemistry
  • Bacterial Outer Membrane Proteins / immunology*
  • Bordetella pertussis / chemistry
  • Bordetella pertussis / immunology*
  • Child
  • Child, Preschool
  • Cross Reactions
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Finland
  • Gliadin / immunology*
  • Glutens / immunology*
  • Humans
  • Immunoglobulin A / analysis
  • Immunoglobulin A / immunology
  • Immunoglobulin G / analysis
  • Immunoglobulin G / immunology
  • Male
  • Middle Aged
  • Virulence Factors, Bordetella / chemistry
  • Virulence Factors, Bordetella / immunology*
  • Whooping Cough / immunology

Substances

  • Antibodies, Bacterial
  • Bacterial Outer Membrane Proteins
  • Immunoglobulin A
  • Immunoglobulin G
  • Virulence Factors, Bordetella
  • pertactin
  • Glutens
  • Gliadin